Your browser doesn't support javascript.
loading
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis.
Prieto-Peña, Diana; Genre, Fernanda; Remuzgo-Martínez, Sara; Pulito-Cueto, Verónica; Atienza-Mateo, Belén; Llorca, Javier; Sevilla-Pérez, Belén; Ortego-Centeno, Norberto; Lera-Gómez, Leticia; Leonardo, María Teresa; Peñalba, Ana; Narváez, Javier; Martín-Penagos, Luis; Rodrigo, Emilio; Miranda-Filloy, José A; Caminal-Montero, Luis; Collado, Paz; Pérez, Javier Sánchez; de Argila, Diego; Rubio, Esteban; Luque, Manuel León; Blanco-Madrigal, Juan María; Galíndez-Agirregoikoa, Eva; Gualillo, Oreste; Martín, Javier; Castañeda, Santos; Blanco, Ricardo; González-Gay, Miguel A; López-Mejías, Raquel.
Afiliação
  • Prieto-Peña D; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Genre F; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Remuzgo-Martínez S; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Pulito-Cueto V; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Atienza-Mateo B; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Llorca J; `López Albo´ Post-Residency Programme, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Sevilla-Pérez B; Epidemiology and Computational Biology Department, School of Medicine, Universidad de Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain.
  • Ortego-Centeno N; Division of Paediatrics, Hospital Universitario San Cecilio, Granada, Spain.
  • Lera-Gómez L; Medicine Department, Universidad de Granada, Granada, Spain.
  • Leonardo MT; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • Peñalba A; Division of Paediatrics, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Narváez J; Division of Paediatrics, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Martín-Penagos L; Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain.
  • Rodrigo E; Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN, Santander, Spain.
  • Miranda-Filloy JA; Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN, Santander, Spain.
  • Caminal-Montero L; Division of Rheumatology, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Collado P; Internal Medicine Dept, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Pérez JS; Division of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • de Argila D; Division of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Rubio E; Division of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Luque ML; Division of Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Blanco-Madrigal JM; Division of Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Galíndez-Agirregoikoa E; Division of Rheumatology, Hospital Universitario de Basurto, Bilbao, Spain.
  • Gualillo O; Division of Rheumatology, Hospital Universitario de Basurto, Bilbao, Spain.
  • Martín J; SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Castañeda S; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS Granada, Granada, Spain.
  • Blanco R; Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
  • González-Gay MA; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
  • López-Mejías R; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.
Sci Rep ; 11(1): 11510, 2021 06 01.
Article em En | MEDLINE | ID: mdl-34075170

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Vasculite / Imunoglobulina A / Polimorfismo de Nucleotídeo Único / Fator Ativador de Células B / Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral / Receptor do Fator Ativador de Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Vasculite / Imunoglobulina A / Polimorfismo de Nucleotídeo Único / Fator Ativador de Células B / Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral / Receptor do Fator Ativador de Células B Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha